Christine Chevreau

Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.

Apurva A Desai, Walter M Stadler, M. Gore, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sorafenib in advanced clear-cell renal-cell carcinoma.

Apurva A Desai, Walter M Stadler, Scott Freeman, 2007, The New England journal of medicine.

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial.

David Pérol, Sylvie Négrier, J. Bay, 2011, The Lancet. Oncology.

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Bohuslav Melichar, A. Ravaud, B. Melichar, 2007, The Lancet.